UroVaxom
Pharmaceutical compound
From Wikipedia, the free encyclopedia
UroVaxom (developmental code names OM-89, OM-8980) is a vaccine against urinary tract infections (UTIs).[3][2][4] It is an extract of 18 strains of killed Escherichia coli administered as an oral tablet once daily for 3 months.[3][1][2] The vaccine is marketed for use in the prevention of recurrent UTIs in some European countries.[3][2] It was also being studied for treatment of prostatitis but was discontinued.[3] UroVaxom was initially developed in the 1980s.[5]
| Vaccine description | |
|---|---|
| Target | Escherichia coli |
| Vaccine type | Inactivated |
| Clinical data | |
| Trade names | UroVaxom |
| Other names | OM-89; OM-8980 |
| Routes of administration | Oral (tablet)[1][2] |
